To view or add a comment, sign in 65,666 followers
A multi- facet approach works best, but any one of these will also be a great start: 1
However, corresponding difference between CagriSema and semaglutide was not significant being -0.4 Percentage (95 Percentage CI, -0.8 to 0.0, p=0.075) [10]
Tirzepatide presents a significant advancement in the pharmacological management of obesity, offering a treatment option that not only aids in substantial body weight reduction but also contributes positively to overall metabolic health
Supplements can support symptom management but should complement, not replace, food strategies
Combining your genetic insights with a detailed drug interaction review supports a more personalized conversation with your provider about which medications need adjustment, monitoring, or alternatives